The former Illinois governor has been undergoing chemotherapy after a diagnosis last month, he told the Sun-Times. “I’m ...
DURIPANC is an investigator-initiated, exploratory, open-label, single-center study in the Netherlands at the Erasmus Medical ...
Ever Evaluation of SIL-204 in Clinically Relevant Orthotopic Models; Analysis Underway with Initial Results Expected in ...
Testing is recommended for those with personal and family histories of several types of cancer — including pancreatic and ...
Pancreatic cancer kills three in four people within the first year. But new research is offering hope to people in years to come.As few as one in ten people survive pancreatic cancer five years after ...